Table 4. Multivariate analysis results in terms of recurrence-free survival and overall survival.
Recurrence free survival | Overall survival | |||||
HR | 95% CI | p | HR | 95% CI | p | |
Age | 1.001 | 0.966-1.036 | 0.975 | 1.013 | 0.978-1.049 | 0.466 |
Sex | 0.842 | 0.310-2.285 | 0.736 | 1.755 | 0.540-5.707 | 0.350 |
Tumor type (primary/secondary) | 1.380 | 0.252-7562 | 0.711 | 3.055 | 0.299-31.204 | 0.346 |
Tumor pathology (carcinoma/sarcoma) | 1.007 | 0.145-6.995 | 0.994 | 2.048 | 0.163-25.742 | 0.579 |
Grade | 2.443 | 1.312-4.549 | 0.005 | 2.032 | 1.005-4.109 | 0.048 |
Stage | 0.939 | 0.511-1.725 | 0.839 | 0.762 | 0.396-1.467 | 0.417 |
Resection margin | 1.749 | 0.532-5.749 | 0.357 | 1.863 | 0.643-5.399 | 0.252 |
Rib resection | 0.066 | 0.016-0.278 | <0.001 | 0.128 | 0.029-0.566 | 0.007 |
Neoadjuvant treatment | 1.308 | 0.503-3.404 | 0.582 | 1.044 | 0.387-2.812 | 0.932 |
Adjuvant treatment | 2.737 | 0.530-14.135 | 0.229 | 1.997 | 0.405-9.838 | 0.395 |
HR: Hazard ratio; CI: Confidence interval. |